Convey Health Solutions (CNVY) Stock Price, News & Analysis

Company Overview

Convey Health Solutions Holdings, Inc. provides technology enabled solutions and advisory services to assist its clients with workflows across product developments, sales, member experience, clinical management, core operations, and business intelligence and analytics. It operates through two segments, Technology Enabled Solutions and Advisory Services. The Technology Enabled Solutions segment offers technology solutions through web-based customizable application that is used to identify, track, and administer contractual services, or benefits provided under a client's plan to its Medicare and Medicaid beneficiaries. It also provides analytics over healthcare data to capture and assess gaps in risk documentation, quality, clinical care, and compliance. The company also offers health plan management, data analytics, supplemental benefit, advisory, and software services. The Advisory Services segment offers sales and marketing strategies, provider network strategies, compliance, star ratings, quality, clinical, pharmacy, analytics, and risk adjustment. It serves government sponsored, medicare advantage, medicare, as well as pharmacy benefits managers. The company was founded in 2001 and is headquartered in Fort Lauderdale, Florida. Convey Health Solutions Holdings, Inc. is a former subsidiary of TPG Cannes Aggregation, L.P.

Key Stats

• Today's Range: $10.51 to $10.51
• 50-Day Range: $10.49 to $10.57
• 52-Week Range: $3.75 to $10.73
• Volume: N/A
• Average Volume: 219,508 shs
• Market Capitalization: $769.27 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CNVY Stock Analysis - Frequently Asked Questions

How were Convey Health Solutions' earnings last quarter?

Convey Health Solutions Holdings, Inc. (NYSE:CNVY) released its quarterly earnings data on Wednesday, November, 10th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.04 by $0.01. The company earned $82.41 million during the quarter, compared to the consensus estimate of $79.10 million. Convey Health Solutions had a positive trailing twelve-month return on equity of 0.08% and a negative net margin of 1.90%.

When did Convey Health Solutions IPO?

Convey Health Solutions (CNVY) raised $200 million in an initial public offering (IPO) on Wednesday, June 16th 2021. The company issued 13,300,000 shares at a price of $14.00-$16.00 per share. BofA Securities, Goldman Sachs, J.P. Morgan and Barclays ​ served as the underwriters for the IPO and TPG Capital BD, LLC, Truist Securities, Canaccord Genuity, AmeriVet Securities and Siebert Williams Shank were co-managers.

What other stocks do shareholders of Convey Health Solutions own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Convey Health Solutions investors own include ImmunityBio (IBRX), NIO (NIO), Applied Therapeutics (APLT), Aveanna Healthcare (AVAH), Carpenter Technology (CRS) and Cytec Industries (CYT).

Company Calendar

• Last Earnings: 11/10/2021
• Today: 7/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Miscellaneous Health & Allied Services
• Sub-Industry: N/A
• Current Symbol: NYSE:CNVY
• CIK: 1787640
• Web: www.conveyhealthsolutions.com
• Phone: 800-559-9358
• Fax: N/A
• Employees: 3,800
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.10)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 36.24
• P/E Growth: N/A
• Net Income: -$9.98 million
• Net Margins: -1.90%
• Pretax Margin: -1.30%
• Return on Equity: 0.08%
• Return on Assets: 0.05%

Debt

• Debt-to-Equity Ratio: 0.50
• Current Ratio: 2.20
• Quick Ratio: 1.60

Sales & Book Value

• Annual Sales: $337.60 million
• Price / Sales: 2.28
• Cash Flow: $0.46 per share
• Price / Cash Flow: 22.90
• Book Value: $7.35 per share
• Price / Book: 1.43

Miscellaneous

• Outstanding Shares: 73,194,000
• Free Float: 68,656,000
• Market Cap: $769.27 million
• Optionable: Not Optionable
• Beta: -0.30